DK2716299T3 - Peptid bfp 4 til fremme af knogledannelse eller vaskulogenese og anvendelse dertil - Google Patents
Peptid bfp 4 til fremme af knogledannelse eller vaskulogenese og anvendelse dertil Download PDFInfo
- Publication number
- DK2716299T3 DK2716299T3 DK12793200.2T DK12793200T DK2716299T3 DK 2716299 T3 DK2716299 T3 DK 2716299T3 DK 12793200 T DK12793200 T DK 12793200T DK 2716299 T3 DK2716299 T3 DK 2716299T3
- Authority
- DK
- Denmark
- Prior art keywords
- vasculogenes
- peptid
- bfp
- promote
- use bone
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110054179A KR101274930B1 (ko) | 2011-06-03 | 2011-06-03 | 골 형성 또는 혈관신생 촉진용 펩타이드 ｂｆｐ 4 및 이의 용도 |
| PCT/KR2012/004346 WO2012165900A2 (ko) | 2011-06-03 | 2012-06-01 | 골 형성 또는 혈관신생 촉진용 펩타이드 ｂｆｐ 4 및 이의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2716299T3 true DK2716299T3 (da) | 2019-08-05 |
Family
ID=47260109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12793200.2T DK2716299T3 (da) | 2011-06-03 | 2012-06-01 | Peptid bfp 4 til fremme af knogledannelse eller vaskulogenese og anvendelse dertil |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20120309675A1 (da) |
| EP (1) | EP2716299B1 (da) |
| JP (1) | JP6025002B2 (da) |
| KR (1) | KR101274930B1 (da) |
| DK (1) | DK2716299T3 (da) |
| ES (1) | ES2739180T3 (da) |
| WO (1) | WO2012165900A2 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015182815A1 (ko) * | 2014-05-26 | 2015-12-03 | 한국생명공학연구원 | Ndrg3 발현 또는 활성 촉진제를 유효성분으로 함유하는 허혈성 질환 예방 및 치료용 약학적 조성물 |
| CN105273039A (zh) * | 2015-11-12 | 2016-01-27 | 河北智同生物制药有限公司 | 一种骨肽提取罐及其应用 |
| KR102169782B1 (ko) | 2016-08-31 | 2020-10-27 | 가톨릭대학교 산학협력단 | 인간 잇몸-유래 줄기세포 및 골전구체 세포를 공동배양하여 형성된 세포 스페로이드 및 이로부터 혈관내피 성장인자의 생산량을 증가시키는 방법 |
| WO2018147517A1 (ko) * | 2017-02-08 | 2018-08-16 | 부경대학교 산학협력단 | 꼬막단백질 유래 펩타이드를 유효성분으로 포함하는 골질환의 예방 또는 치료용 조성물 |
| CN111214649B (zh) * | 2020-02-27 | 2023-06-27 | 广州领晟医疗科技有限公司 | Bm23肽在制备治疗缺血性脑血管疾病的药物中的应用 |
| CN115322245A (zh) * | 2021-06-30 | 2022-11-11 | 北京泽勤生物医药有限公司 | 提高成骨细胞活性的多肽 |
| KR20250017027A (ko) * | 2023-07-26 | 2025-02-04 | 덕성여자대학교 산학협력단 | Ccl8 결합 펩타이드를 포함하는 vegf 유도-혈관신생 억제용 조성물. |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6150328A (en) | 1986-07-01 | 2000-11-21 | Genetics Institute, Inc. | BMP products |
| EP1364655B1 (en) * | 1996-03-22 | 2010-12-29 | Stryker Corporation | Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma |
| WO2000047114A1 (en) * | 1999-02-12 | 2000-08-17 | Collagenesis, Inc. | Injectable collagen-based delivery system for bone morphogenic proteins |
| US20040067505A1 (en) * | 2001-09-26 | 2004-04-08 | Enrique Alvarez | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| JP2008169116A (ja) * | 2005-04-18 | 2008-07-24 | Tokyo Medical & Dental Univ | Ｂｍｐ−７を含む抗ｃ型肝炎ウイルス剤 |
| WO2008014054A2 (en) * | 2006-07-27 | 2008-01-31 | Centocor, Inc. | Bmp-7 variant compositions, methods and uses |
| WO2009139525A1 (en) * | 2008-05-16 | 2009-11-19 | Industry Foundation Of Chonnam National University | An synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide |
| US8025872B2 (en) * | 2008-05-16 | 2011-09-27 | Industry Foundation Of Chonnam National University | Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same |
| EP2303911B1 (en) | 2008-06-20 | 2012-08-15 | Industry Foundation Of Chonnam National University | A synthetic peptide consisting of bone forming peptide 2(bfp 2) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide |
| EP2337795A2 (en) * | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| KR100999831B1 (ko) | 2010-02-26 | 2010-12-09 | 오스템임플란트 주식회사 | 조골세포 분화능을 증진시키는 올리고펩타이드 |
-
2011
- 2011-06-03 KR KR1020110054179A patent/KR101274930B1/ko active IP Right Grant
-
2012
- 2012-06-01 US US13/486,035 patent/US20120309675A1/en not_active Abandoned
- 2012-06-01 JP JP2014513444A patent/JP6025002B2/ja active Active
- 2012-06-01 DK DK12793200.2T patent/DK2716299T3/da active
- 2012-06-01 EP EP12793200.2A patent/EP2716299B1/en active Active
- 2012-06-01 WO PCT/KR2012/004346 patent/WO2012165900A2/ko unknown
- 2012-06-01 ES ES12793200T patent/ES2739180T3/es active Active
-
2014
- 2014-01-13 US US14/153,191 patent/US9238055B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012165900A3 (ko) | 2013-03-28 |
| EP2716299A4 (en) | 2014-12-24 |
| KR20120134940A (ko) | 2012-12-12 |
| WO2012165900A2 (ko) | 2012-12-06 |
| US20120309675A1 (en) | 2012-12-06 |
| EP2716299A2 (en) | 2014-04-09 |
| US20140200174A1 (en) | 2014-07-17 |
| EP2716299B1 (en) | 2019-05-22 |
| KR101274930B1 (ko) | 2013-06-17 |
| ES2739180T3 (es) | 2020-01-29 |
| US9238055B2 (en) | 2016-01-19 |
| JP6025002B2 (ja) | 2016-11-16 |
| JP2014516547A (ja) | 2014-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3358011T3 (da) | Peptid til inducering af regenerering af væv og anvendelse deraf | |
| SI2935303T1 (sl) | 4'-fluoro-nukleozidi, 4'-fluoro-nukleotidi in njihovi analogi za zdravljenje HCV | |
| DK2903600T3 (da) | Virusholdig formulering og anvendelse deraf | |
| DK2970398T3 (da) | Præfusions-rsv-f-proteiner og anvendelse deraf | |
| ME03075B (me) | Prolaktin receptor vezujući proteini i njihova upotreba | |
| DK2920313T3 (da) | Rekombinante adenovira og anvendelse deraf | |
| BR112015001211A2 (pt) | novos ácidos 5-aminotetra-hidroquinolina-2-carboxílicos e sua utilização | |
| DK2771041T3 (da) | Sammensætninger og anvendelse deraf ved knogleheling | |
| BR112013013663A2 (pt) | ácidos 1-benzilcicloalquilcarboxílicos substituídos e sua utilização | |
| CO7020851A2 (es) | Proteínas y péptidos modificados | |
| DK3663399T3 (da) | Modificerede factor IX-polypeptider og anvendelser deraf | |
| DK2744456T3 (da) | Forbedringer ved eller i forbindelse med proteser og ortoser | |
| SI2726092T1 (sl) | Serpin fuzijski polipeptidi in načini njihove uporabe | |
| DK2552434T3 (da) | Peptider og anvendelse deraf | |
| DK2920197T3 (da) | Prolinlåste sammenhæftede peptider og anvendelser deraf | |
| DK2691443T3 (da) | Konjugerede lipomerer og anvendelser af disse | |
| DK3168229T3 (da) | Fremstilling af proteiner og polypeptider. | |
| DK3088353T3 (da) | Bilirubinpartikler og deres fremstilling til anvendelse i terapi | |
| CO6801713A2 (es) | Heteroarilos y sus usos | |
| BR112014000049A2 (pt) | pirrolotriazinas substituídas com hidroximelilarilo e sua utilização | |
| DK2716299T3 (da) | Peptid bfp 4 til fremme af knogledannelse eller vaskulogenese og anvendelse dertil | |
| DK2945642T3 (da) | Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme | |
| DK2917231T3 (da) | Lipopeptider til anvendelse ved behandling af leversygdomme og hjerte-kar-sygdomme | |
| DK2600715T3 (da) | Flydende ST-246-formuleringer og fremgangsmåder | |
| DK3173102T3 (da) | FGFR-FC-fusionsprotein og anvendelse deraf |